AIM ImmunoTech AIM
NYSE AIM
$0.16 -0.01 (-5.88%)
At close: Oct 22, 2026 · 4:00 PM EDT

AIM ImmunoTech (AIM) Change in Acquisitions & Divestments (2020 - 2021)

Updated

Analysis

AIM ImmunoTech (AIM) Change in Acquisitions & Divestments (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 AIM ImmunoTech 2.76 Mn -18.54 Mn 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -426,000.00
Mar 31, 2021 2.04 Mn
Dec 31, 2020 1.55 Mn
Jun 30, 2020 -5.62 Mn
Mar 31, 2020 14.12 Mn
API Access

AIM ImmunoTech Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=AIM&period=max&api_key=YOUR_API_KEY